TrialPediatric rheumatology online journal2022

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis.

Maarit Tarkiainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.